COMPARING SHOBHANJANA TWAK QWATHA AND DHANYAMLA PARISHEKA FOR TREATING RHEUMATOID ARTHRITIS

A Randomized Clinical Study To Evaluate The Efficacy Of Shobhanjana Twak Qwatha (Moringa oleifera Lam) Parisheka On Inflammatory Markers In The Management Of Amavata with special reference To Rheumatoid Arthritis - STQP

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106251

Enrollment

Registered

2026-03-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients confirmed with Positive Anti CCP test. Patients presenting with sandhi shotha (swelling of joints), sandhi shola(joints pain), and any of two samanya lakshanas of Amavata i.e, angamardha (bodyache), aruchi (anorexia), trushna (thirst), alasya (lack of enthusiasm), gourava (heaviness), jwara (fever), apaka (indigestion) patients fit for parisheka sweda.

Exclusion criteria

Exclusion criteria: Patinets with other systemic illness like uncontrolled diabetes mellitus and hypertension etc All connective tissue disorder other than Rheumatoid arthritis. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Comparing the effect of Shobhanjana Twak Qwatha Parisheka and Dhanyamla Parisheka on inflammatory markers in the Amavata w.s.r. to Rheumatoid Arthritis.Timepoint: Before treatment 0th day, after treatment 7th day	—

Secondary

Measure	Time frame
Improvement in quality of life.Timepoint: Before treatment 0th day, after treatment 7th day	—

Countries

India

Contacts

Public ContactDR MANJUNATH KANTHI

SDM COLLEGE OF AYURVEDA, HOSPITAL AND RESEARCH CENTER, UDUPI

kanthipk03@gmail.com9844469138

Outcome results